Table 2. Details of the clinicopathological feature-based classification of KIRP and LUAD samples analyzed in the current study.

Sr. No.	Clinicopathological feature	Sample count	Total sample count	Sample count with missing information	Total final sample count undertaken in analysis
Clinicopathological feature-based classification of KIRP samples
1	Cancer stage distribution		290
	Stage 1	140
	Stage 2	21		89	201
	Stage 3	29
	Stage 4	11
2	Geographical distribution
	Caucasian	206
	African-American	61		17	273
	Asian	06
3	Gender distribution
	Male	214		00	290
	Female	76
4	Age distribution
	21–40 years	16
	41–60 years	119		03	287
	61–80 years	139
	81–100 years	13
Clinicopathological feature-based classification of LUAD samples
1	Cancer stage distribution		515
	Stage 1	277
	Stage 2	125		0	515
	Stage 3	96
	Stage 4	28
2	Geographical distribution
	Caucasian	387
	African-American	51		69	446
	Asian	08
3	Gender distribution
	Male	238		01	514
	Female	276
4	Age distribution
	21–40 years	12
	41–60 years	90		277	283
	61–80 years	149
	81–100 years	32